Prot# GFT505-315-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis.

Project: Research project

Project Details

StatusActive
Effective start/end date9/28/169/28/21

Funding

  • Covance Inc. (Prot# GFT505-315-1)
  • Genfit SA (Prot# GFT505-315-1)